Compound Detail
CHEMBL770
TOLAZOLINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL770 |
| Name | TOLAZOLINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | JIVZKJJQOZQXQB-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
4
Targets
7
Activities
3
Assay Types
0
PK Parameters
20
Publications
4
Known Names
3
Indications
Molecular Properties
160.2
MW (Da)
1.23
ALogP
2
HBA
1
HBD
24.4
PSA (Ų)
0.69
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1985 |
| Availability | Discontinued |
| Chirality | Achiral |
Indications
Arthralgia Cardiovascular Diseases Myalgia
ATC Classification
C04AB02
tolazoline
Level 1: CARDIOVASCULAR SYSTEM
Level 2: PERIPHERAL VASODILATORS
M02AX02
tolazoline
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
Activity Summary
Kd 3 meas. best 5.82
IC50 2 meas. best 6.55
Ki 2 meas. best 6.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adrenergic receptor alpha-2 CHEMBL2093864 | Ki | 6.75 | 6.75 | 180.0 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | IC50 | 6.55 | 6.55 | 280.0 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Kd | 5.82 | 5.82 | 1513.6 | 1 |
| Trace amine-associated receptor 1 CHEMBL5857 | Ki | 5.79 | 5.79 | 1640.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Kd | 5.66 | 5.66 | 2187.8 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Kd | 5.41 | 5.41 | 3890.4 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 13215 | 10.1021/jm00211a010 | No relevant target | 4 |
| 22381672 | 10.1016/j.bmc.2012.02.009 | Rattus norvegicus | 4 |
| 6142954 | 10.1021/jm00370a011 | Adrenergic receptor alpha-2 | 3 |
| 6142954 | 10.1021/jm00370a011 | Adrenergic receptor alpha-1 | 3 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Peroxisome proliferator-activated receptor gamma | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Glucocorticoid receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 6142954 | 10.1021/jm00370a011 | Adrenergic receptor alpha | 2 |
Data from ChEMBL 36 via Core Engine